Inflammatory Protein Pathway Uncovered by Cedars-Sinai Investigators

Cedars-Sinai investigators recently made advancements in understanding the cellular process behind inflammation, one of the body's critical immune responses. Their findings, published in Science Immunology, shed light on the steps leading to the production of IL-1 beta, a powerful inflammatory protein signal associated with various infections and inflammatory diseases.

The researchers, led by Dr. Andrea Wolf and Dr. David Underhill, focused on chronic inflammation, a condition where the body remains stuck in an inflammatory state. While inflammation is crucial for a healthy immune system, chronic inflammation can lead to severe conditions such as Type 2 diabetes, heart disease, and depression. Understanding the cellular process triggering inflammation is crucial for finding new treatments for chronic inflammation.

Building on their previous research from 2016, which revealed the enzyme hexokinase's inflammatory role, the scientists uncovered additional steps in the process. They found that hexokinase leaves the mitochondria, the cell's energy-generating component, initiating an immune response.

This triggers the clustering of a channel called VDAC in the mitochondrial membrane, which interacts with another protein called NLRP3 to initiate the assembly of inflammasomes. Ultimately, this process leads to the production of IL-1 beta, contributing to inflammation.

The researchers utilized laboratory mice-derived cells and employed inhibitors and gene-editing technology to identify the vital proteins involved in triggering inflammation. They also used a super-resolution microscope to visualize and measure the steps of this inflammatory process at the cellular level.

Targeting specific steps in this pathway is essential, as these components also play a crucial role in maintaining cellular energy. By focusing on the inflammatory role rather than completely inhibiting the pathway, the researchers aim to develop targeted treatments for inflammatory diseases.

The team hopes to continue investigating the cellular steps leading to hexokinase's role in inflammasome activation and the subsequent effects. Additionally, they're using the insights gained from this study to explore potential therapeutic strategies that target this inflammatory pathway in different diseases. This research provides a more comprehensive understanding of the molecular details involved in inflammation, offering new possibilities for interventions and treatments.